Structure Therapeutics Inc.
GPCR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$65,712 | -$61,661 | -$46,833 | -$36,479 |
| Dep. & Amort. | $356 | $291 | $274 | $273 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7,495 | $7,509 | $5,918 | $5,831 |
| Change in WC | $9,512 | $3,083 | -$6,803 | -$534 |
| Other Non-Cash | -$2,647 | -$3,780 | -$4,785 | -$5,558 |
| Operating Cash Flow | -$50,996 | -$54,558 | -$52,229 | -$36,467 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,572 | -$232 | -$314 | -$16 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$248,824 | -$88,826 | -$116,106 | -$132,252 |
| Inv. Sales/Matur. | $195,919 | $138,000 | $150,453 | $165,500 |
| Other Inv. Act. | $5,158 | $0 | $0 | $0 |
| Investing Cash Flow | -$49,319 | $48,942 | $34,033 | $33,232 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $57,058 | $519 | $966 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$855 | -$2 | -$157 | $615 |
| Financing Cash Flow | $56,203 | $517 | $809 | $615 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$44,112 | -$5,099 | -$17,387 | -$2,620 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $147,024 | $152,123 | $169,510 | $172,130 |
| End Cash | $102,912 | $147,024 | $152,123 | $169,510 |
| Free Cash Flow | -$52,568 | -$54,790 | -$52,543 | -$36,483 |